The Scientific and Therapeutic Rationale for Off-Label Treatments in Amyotrophic Lateral Sclerosis

Area of Science:

• Neuroscience
• Pharmacology
• Medical Research

Background:

• Amyotrophic lateral sclerosis (ALS) presents complex pathological mechanisms including neuroinflammation, oxidative stress, and mitochondrial dysfunction.
• Current pharmacological treatments for ALS lack dramatic efficacy for most patients.
• Multiple underlying mechanisms offer potential targets for novel therapeutic strategies.

Purpose of the Study:

• To identify alternative and off-label treatments for amyotrophic lateral sclerosis (ALS).
• To evaluate treatments targeting known ALS pathological mechanisms with evidence from human trials.
• To explore the potential of combination therapies for future ALS treatment development.

Main Methods:

• Systematic review of 15 years of ALSUntangled reviews.
• Identification of treatments targeting at least one ALS mechanism (neuroinflammation, oxidative stress, etc.).
• Inclusion of treatments with at least one human trial demonstrating meaningful benefits.

Main Results:

• Eight alternative and off-label treatments were identified.
• These treatments target key pathological mechanisms implicated in ALS.
• Each identified treatment has supporting evidence from human trials indicating potential benefits.

Conclusions:

• The identified alternative and off-label treatments show promise for managing ALS.
• Overlapping pathological mechanisms suggest combination therapies could be beneficial.
• Future research should focus on developing combination treatment strategies for ALS.